ArticleOncogene2022

Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.

Natsumi Tsuboyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.